Literature DB >> 29221229

Tracking occult pN2 disease after mediastinal dissection in early stage lung cancer.

Cristiano Benato1, Sara Pilotto2, Maurizio Infante1, Emilio Bria2.   

Abstract

Entities:  

Year:  2017        PMID： 29221229      PMCID： PMC5708476          DOI： 10.21037/jtd.2017.07.118

Source DB:  PubMed          Journal:  J Thorac Dis        ISSN： 2072-1439            Impact factor:   2.895


× No keyword cloud information.
  18 in total

Review 1.  The role of lymphadenectomy in lung cancer surgery.

Authors:  Antonio D'Andrilli; Federico Venuta; Erino A Rendina
Journal:  Thorac Surg Clin       Date:  2012-01-11       Impact factor: 1.750

Review 2.  Lymph node dissection for lung cancer: significance, strategy, and technique.

Authors:  Shun-ichi Watanabe; Hisao Asamura
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

3.  Incidence, Risk Factors, and Analysis of Survival of Unexpected N2 Disease in Stage I Non-Small Cell Lung Cancer.

Authors:  Alfonso Fiorelli; Dariusz Sagan; Lukasz Mackiewicz; Lucio Cagini; Elisa Scarnecchia; Paolo Chiodini; Francesco Paolo Caronia; Francesco Puma; Mario Santini; Mark Ragusa
Journal:  Thorac Cardiovasc Surg       Date:  2015-01-28       Impact factor: 1.827

Review 4.  2nd ESMO Consensus Conference in Lung Cancer: locally advanced stage III non-small-cell lung cancer.

Authors:  W E E Eberhardt; D De Ruysscher; W Weder; C Le Péchoux; P De Leyn; H Hoffmann; V Westeel; R Stahel; E Felip; S Peters
Journal:  Ann Oncol       Date:  2015-04-20       Impact factor: 32.976

5.  Lymph node sampling in lung cancer: how should it be done?

Authors:  T Naruke; R Tsuchiya; H Kondo; H Nakayama; H Asamura
Journal:  Eur J Cardiothorac Surg       Date:  1999-09       Impact factor: 4.191

6.  Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 Trial.

Authors:  Gail E Darling; Mark S Allen; Paul A Decker; Karla Ballman; Richard A Malthaner; Richard I Inculet; David R Jones; Robert J McKenna; Rodney J Landreneau; Valerie W Rusch; Joe B Putnam
Journal:  J Thorac Cardiovasc Surg       Date:  2011-03       Impact factor: 5.209

7.  Magnitude of benefit of adjuvant chemotherapy for non-small cell lung cancer: meta-analysis of randomized clinical trials.

Authors:  Emilio Bria; Richard J Gralla; Harry Raftopoulos; Federica Cuppone; Michele Milella; Isabella Sperduti; Paolo Carlini; Edmondo Terzoli; Francesco Cognetti; Diana Giannarelli
Journal:  Lung Cancer       Date:  2008-06-18       Impact factor: 5.705

8.  Adjuvant chemotherapy, with or without postoperative radiotherapy, in operable non-small-cell lung cancer: two meta-analyses of individual patient data.

Authors:  R Arriagada; A Auperin; S Burdett; J P Higgins; D H Johnson; T Le Chevalier; C Le Pechoux; M K B Parmar; J P Pignon; R L Souhami; R J Stephens; L A Stewart; J F Tierney; H Tribodet; J van Meerbeeck
Journal:  Lancet       Date:  2010-03-24       Impact factor: 79.321

9.  The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.

Authors:  Valerie W Rusch; Hisao Asamura; Hirokazu Watanabe; Dorothy J Giroux; Ramon Rami-Porta; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

10.  Impact of Examined Lymph Node Count on Precise Staging and Long-Term Survival of Resected Non-Small-Cell Lung Cancer: A Population Study of the US SEER Database and a Chinese Multi-Institutional Registry.

Authors:  Wenhua Liang; Jiaxi He; Yaxing Shen; Jianfei Shen; Qihua He; Jianrong Zhang; Gening Jiang; Qun Wang; Lunxu Liu; Shugeng Gao; Deruo Liu; Zheng Wang; Zhihua Zhu; Calvin S H Ng; Chia-Chuan Liu; René Horsleben Petersen; Gaetano Rocco; Thomas D'Amico; Alessandro Brunelli; Haiquan Chen; Xiuyi Zhi; Bo Liu; Yixin Yang; Wensen Chen; Qian Zhou; Jianxing He
Journal:  J Clin Oncol       Date:  2016-12-28       Impact factor: 44.544
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.